{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:22:40Z","timestamp":1786998160467,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Institute for the Promotion of Innovation through Science and Technology"},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.xphs.2016.03.027","type":"journal-article","created":{"date-parts":[[2016,5,10]],"date-time":"2016-05-10T10:46:14Z","timestamp":1462877174000},"page":"2904-2912","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Gastrointestinal and Systemic Monitoring of Posaconazole in Humans After Fasted and Fed State Administration of a Solid Dispersion"],"prefix":"10.1016","volume":"105","author":[{"given":"Bart","family":"Hens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Corsetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Brouwers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Augustijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2016.03.027_bib1","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A\u00a0theoretical basis for a biopharmaceutic drug classification: the correlation of in\u00a0vitro drug product dissolution and in\u00a0vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2016.03.027_bib2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1124\/pr.112.005660","article-title":"Strategies to address low drug solubility in discovery and development","volume":"65","author":"Williams","year":"2013","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.xphs.2016.03.027_bib3","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1517\/17425247.2014.911728","article-title":"Refining stability and dissolution rate of amorphous drug formulations","volume":"11","author":"Grohganz","year":"2014","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.xphs.2016.03.027_bib4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1021\/acs.molpharmaceut.5b00652","article-title":"Dissolution of danazol amorphous solid dispersions: supersaturation and phase behavior as a function of drug loading and polymer type","volume":"13","author":"Jackson","year":"2016","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2016.03.027_bib5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ijpharm.2012.07.015","article-title":"Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: formulation and process considerations","volume":"453","author":"Paudel","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2016.03.027_bib6","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1007\/s11095-013-1038-z","article-title":"Toward the establishment of standardized in\u00a0vitro tests for lipid-based formulations, part 3: understanding supersaturation versus precipitation potential during the in\u00a0vitro digestion of type I, II, IIIA, IIIB and IV lipid-based formulations","volume":"30","author":"Williams","year":"2013","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2016.03.027_bib7","doi-asserted-by":"crossref","first-page":"4982","DOI":"10.1002\/jps.22226","article-title":"Precipitation of a poorly soluble model drug during in\u00a0vitro lipolysis: characterization and dissolution of the precipitate","volume":"99","author":"Sassene","year":"2010","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2016.03.027_bib8","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ejpb.2011.04.005","article-title":"Precipitation in the small intestine may play a more important role in the in\u00a0vivo performance of poorly soluble weak bases in the fasted state: case example nelfinavir","volume":"79","author":"Shono","year":"2011","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2016.03.027_bib9","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1007\/s11095-011-0506-6","article-title":"Precipitation in and supersaturation of contents of the upper small intestine after administration of two weak bases to fasted adults","volume":"28","author":"Psachoulias","year":"2011","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2016.03.027_bib10","article-title":"Supersaturation and precipitation of posaconazole upon entry in the upper small intestine in humans","author":"Hens","year":"2015","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2016.03.027_bib11","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2165\/11592630-000000000-00000","article-title":"Effect of pH and comedication on gastrointestinal absorption of posaconazole: monitoring of intraluminal and plasma drug concentrations","volume":"50","author":"Walravens","year":"2011","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.xphs.2016.03.027_bib12","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1128\/AAC.05000-14","article-title":"Effect of a high-fat meal on the pharmacokinetics of 300-milligram posaconazole in a solid oral tablet formulation","volume":"59","author":"Kersemaekers","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.xphs.2016.03.027_bib13","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1021\/mp100377m","article-title":"Excipient-mediated supersaturation stabilization in human intestinal fluids","volume":"8","author":"Bevernage","year":"2011","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2016.03.027_bib14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1021\/la503644m","article-title":"Impact of polymer conformation on the crystal growth inhibition of a poorly water-soluble drug in aqueous solution","volume":"31","author":"Schram","year":"2015","journal-title":"Langmuir"},{"key":"10.1016\/j.xphs.2016.03.027_bib15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ijpharm.2013.05.013","article-title":"Drug precipitation inhibitors in supersaturable formulations","volume":"453","author":"Xu","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2016.03.027_bib16","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.1128\/AAC.00222-12","article-title":"Single-dose phase I study to evaluate the pharmacokinetics of posaconazole in new tablet and capsule formulations relative to oral suspension","volume":"56","author":"Krishna","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.xphs.2016.03.027_bib17","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s40265-015-0348-3","article-title":"Posaconazole: a review of the gastro-resistant tablet and intravenous solution in invasive fungal infections","volume":"75","author":"McKeage","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.xphs.2016.03.027_bib18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s12281-014-0185-y","article-title":"Update on posaconazole pharmacokinetics: comparison of old and new formulations","volume":"8","author":"Percival","year":"2014","journal-title":"Curr Fungal Infect Rep"},{"key":"10.1016\/j.xphs.2016.03.027_bib19","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1128\/AAC.02448-13","article-title":"Posaconazole tablet pharmacokinetics: lack of effect of concomitant medications altering gastric pH and gastric motility in healthy subjects","volume":"58","author":"Kraft","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.xphs.2016.03.027_bib20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2165\/00003088-200544020-00006","article-title":"Oral bioavailability of posaconazole in fasted healthy subjects: comparison between three regimens and basis for clinical dosage recommendations","volume":"44","author":"Ezzet","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.xphs.2016.03.027_bib21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nrgastro.2012.57","article-title":"The migrating motor complex: control mechanisms and its role in health and disease","volume":"9","author":"Deloose","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.xphs.2016.03.027_bib22","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejpb.2009.01.004","article-title":"Assessing gastrointestinal motility and disintegration profiles of magnetic tablets by a novel magnetic imaging device and gamma scintigraphy","volume":"74","author":"Goodman","year":"2010","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2016.03.027_bib23","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ijpharm.2011.07.031","article-title":"In\u00a0vivo imaging of drug delivery systems in the gastrointestinal tract","volume":"417","author":"Weitschies","year":"2011","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2016.03.027_bib24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejps.2004.03.004","article-title":"Food effects on tablet disintegration","volume":"22","author":"Abrahamsson","year":"2004","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2016.03.027_bib25","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1081\/DDC-100102236","article-title":"Investigation of prandial effects on hydrophilic matrix tablets","volume":"25","author":"Abrahamsson","year":"1999","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.xphs.2016.03.027_bib26","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ejpb.2010.10.009","article-title":"Food-dependent disintegration of immediate release fosamprenavir tablets: in\u00a0vitro evaluation using magnetic resonance imaging and a dynamic gastrointestinal system","volume":"77","author":"Brouwers","year":"2011","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2016.03.027_bib27","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1021\/mp500022u","article-title":"Intragastric volume changes after intake of a high-caloric, high-fat standard breakfast in healthy human subjects investigated by MRI","volume":"11","author":"Koziolek","year":"2014","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2016.03.027_bib28","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1021\/mp300604u","article-title":"Simulating the postprandial stomach: physiological considerations for dissolution and release testing","volume":"10","author":"Koziolek","year":"2013","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2016.03.027_bib29","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1021\/mp500210c","article-title":"Quantification of gastrointestinal liquid volumes and distribution following a 240 mL dose of water in the fasted state","volume":"11","author":"Mudie","year":"2014","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2016.03.027_bib30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/jps.22750","article-title":"Supersaturating drug delivery systems: fast is not necessarily good enough","volume":"101","author":"Augustijns","year":"2012","journal-title":"J\u00a0Pharm Sci"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916413304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916413304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T16:45:28Z","timestamp":1589647528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354916413304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0022354916413304"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2016.03.027","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gastrointestinal and Systemic Monitoring of Posaconazole in Humans After Fasted and Fed State Administration of a Solid Dispersion","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2016.03.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}